Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
As-needed budesonide/formoterol versus maintenance budesonide in mild asthma
ACTRN12616000377437Phase 3Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in asthma comparing As-needed budesonide/formoterol with Maintenance budesonide plus as-needed terbutaline (2 arms). Primary endpoint: Severe asthma exacerbation rate. Started May 2016; status: completed.
02
Drugs
budesonide + formoterolbudesonideterbutaline
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12616000377437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000377437.